Z. Zachar

发表

Nuclear pre-mRNA metabolism: channels and tracks.

P. Bingham, J. Kramer, Z. Zachar, 1994, Trends in cell biology.

A phase 1 study of first-in-class agent CPI-613 in combination with FOLFIRINOX for metastatic pancreatic cancer

Wei Zhang, L. Miller, U. Topaloglu, 2017 .

A strategically designed small molecule attacks alpha-ketoglutarate dehydrogenase in tumor cells through a redox process

P. Bingham, B. Keppler, A. Kennedy, 2014, Cancer & metabolism.

Molecular cloning and genetic analysis of the suppressor-of-white-apricot locus from Drosophila melanogaster

D. Garza, P. Bingham, Z. Zachar, 1987, Molecular and cellular biology.

A detailed developmental and structural study of the transcriptional effects of insertion of the Copia transposon into the white locus of Drosophila melanogaster.

D. Davison, D. Garza, P. Bingham, 1985, Genetics.

The solvability of the equivalence problem for deterministic frontier-to-root tree transducers

Z. Zachar, Z. Zachar, 1979, Acta Cybern..

Looking at mRNA splicing and transport in situ.

P. Bingham, J. Kramer, Z. Zachar, 1994, Methods in cell biology.

Microbial interference and colonization of the murine gastrointestinal tract by Listeria monocytogenes

D. Savage, Z. Zachar, 1979, Infection and immunity.

Concanavalin A-mediated affinity film for Treponema pallidum

J. Baseman, Z. Zachar, N. S. Hayes, 1980, Infection and immunity.

Suppressive Insertion-Induced Mutations in Drosphila

P. Bingham, Z. Zachar, 1989 .

Evidence that two mutations, wDZL and z1 , affecting synapsis-dependent genetic behavior of white are transcriptional regulatory mutations

P. Bingham, Z. Zachar, 1985, Cell.

Evidence that a regulatory gene autoregulates splicing of its transcript.

P. Bingham, Z. Zachar, T. Chou, 1987, The EMBO journal.

Developmental expression of a regulatory gene is programmed at the level of splicing.

P. Bingham, Z. Zachar, T. Chou, 1987, The EMBO journal.

Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy

P. Bingham, Z. Zachar, Shawn D. Stuart, 2014, Expert review of clinical pharmacology.

Evidence for channeled diffusion of pre-mRNAs during nuclear RNA transport in metazoans

P. Bingham, J. Kramer, Z. Zachar, 1993, The Journal of cell biology.

Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo

P. Bingham, J. Marecek, K. Lee, 2011, Journal of Molecular Medicine.

Regulation of white locus expression: The structure of mutant alleles at the white locus of Drosophila melanogaster

P. Bingham, Z. Zachar, 1982, Cell.

Cancer Metabolism: A Nexus of Matter, Energy, and Reactive Oxygen Species

P. Bingham, Z. Zachar, Shawn D. Stuart, 2014 .

On the molecular basis of transvection effects and the regulation of transcription.

P. Bingham, Z. Zachar, C. H. Chapman, 1985, Cold Spring Harbor symposia on quantitative biology.

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.

Wei Zhang, L. Miller, U. Topaloglu, 2017, The Lancet. Oncology.

On/off regulation of gene expression at the level of splicing.

P. Bingham, Z. Zachar, T. Chou, 1988, Trends in genetics : TIG.

Analysis of autoregulation at the level of pre-mRNA splicing of the suppressor-of-white-apricot gene in Drosophila.

P. Bingham, J. Kramer, Z. Zachar, 1994, Genetics.

The Pyruvate Dehydrogenase Complex in Cancer: Implications for the Transformed State and Cancer Chemotherapy

P. Bingham, Z. Zachar, 2012 .

Metabolic PET Imaging in Oncology.

P. Bingham, A. Mintz, K. Sai, 2017, AJR. American journal of roentgenology.

Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas

Z. Zachar, P. M. Bingham, Paul M. Bingham, 2023, International journal of molecular sciences.

Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613

P. Bingham, Z. Zachar, Shawn D. Stuart, 2022, PloS one.

A phase 1 study of first-in-class agent CPI-613 in combination with FOLFIRINOX for metastatic pancreatic cancer

Wei Zhang, L. Miller, U. Topaloglu, 2017, The Lancet. Oncology.